This may result in uncertainty about the accuracy of the diagnosis and require a cautious drug holiday, an apomorphine or l‐DOPA challenge test, and, if doubt remains about the diagnosis, a dopamine transporter single‐photon emission computed tomography (SPECT) scan to revalidate the diagnosis of Parkinson's disease. The gene discussed is SLC6A3; the disease is Parkinson disease.